Dipna Pharmachem (BOM:543594) Debt-to-Equity : 0.52 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Dipna Pharmachem Debt-to-Equity?

Dipna Pharmachem's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹69 Mil. Dipna Pharmachem's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹125 Mil. Dipna Pharmachem's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹375 Mil. Dipna Pharmachem's debt to equity for the quarter that ended in Mar. 2024 was 0.52.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Dipna Pharmachem's Debt-to-Equity or its related term are showing as below:

BOM:543594' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.52 Med: 5.86 Max: 21.74
Current: 0.52

During the past 5 years, the highest Debt-to-Equity Ratio of Dipna Pharmachem was 21.74. The lowest was 0.52. And the median was 5.86.

BOM:543594's Debt-to-Equity is ranked worse than
51.63% of 552 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs BOM:543594: 0.52

Dipna Pharmachem Debt-to-Equity Historical Data

The historical data trend for Dipna Pharmachem's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dipna Pharmachem Debt-to-Equity Chart

Dipna Pharmachem Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

17.48

21.74

5.86

0.65

0.52

Dipna Pharmachem Semi-Annual Data
	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial			5.86	0.34	0.65	0.72	0.52

Competitive Comparison of Dipna Pharmachem's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, Dipna Pharmachem's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dipna Pharmachem's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dipna Pharmachem's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Dipna Pharmachem's Debt-to-Equity falls into.

Dipna Pharmachem Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Dipna Pharmachem's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(68.98	+	125.47)	/	375.187
	=	0.52

Dipna Pharmachem's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(68.98	+	125.47)	/	375.187
	=	0.52

Dipna Pharmachem (BOM:543594) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Dipna Pharmachem Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Dipna Pharmachem's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Dipna Pharmachem (BOM:543594) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dipna Pharmachem Ltd (BOM:543594) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, GJ, IND, 380 055

Website

https://www.dipnapharmachem.com

Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti - Bacteria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone and others.

Dipna Pharmachem (BOM:543594) Headlines

No Headlines